<DOC>
	<DOCNO>NCT00273013</DOCNO>
	<brief_summary>This study investigate whether 14 day dose GW274150 beneficial effect model asthma type inflammation call allergen-induced late asthmatic response . This compare response treatment dummy ( placebo ) tablet treatment asthma call Singulair ( montelukast ) . Subjects study receive 3 treatment random order . The study double-blind subject know treatment take give time .</brief_summary>
	<brief_title>Study With GW274150 In Patients With Mild Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Inclusion criterion : Mild asthma : take reliever medication ( e.g . salbutamol ) . Screening involves measure response lung challenge agent : allergen , AMP , methacholine . Only specific type response eligible study . Exclusion criterion : Recent steroid treatment . Significant illnesses disease asthma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>asthma</keyword>
	<keyword>allergen challenge</keyword>
</DOC>